Cambrex is an innovative life sciences company with a refreshingly human approach to the way we do business. Our pharmaceutical products, technologies and expertise accelerate your small molecule therapeutics into the market.Learn more
Cambrex has announced that it has acquired PharmaCore Inc., a privately-owned company located in High Point, North Carolina, specializing in developing, manufacturing and scaling up small molecule APIs for clinical phase projects.
The acquisition expands our portfolio of small molecule API development and manufacturing services and provides the capability and expertise to efficiently develop early clinical phase products and new technologies.Learn more
Active Pharmaceutical Ingredients and dynamic people come together to create the Cambrex effect. Watch our video to learn how we can accelerate your small molecule therapeutics into the market.
Cambrex is a leading global supplier of more than 90 generic APIs.
With API R&D and cGMP facilities in the USA and Europe, Cambrex can support your project in regulated, emerging and developing markets. We are in your neighbourhood, wherever you are.See our facilities